Last week’s headlines included news of a launch of a new ‘precision-grade’ creatine monohydrate by Jenerise, France announcing a ban of CBD edibles, and the introduction of the Dietary Supplements Access Act in the U.S. Senate.
Jenerise launches precision-grade creatine monohydrate
Creatine innovation and education company Jenerise has launched a ‘precision-grade’ creatine monohydrate that seeks to raise creatine quality-standards across the dietary supplement market.
Founded in 2024 by father-daughter duo Steve and Rachael Jennings, Jenerise is UK-based ingredient and supplement company that has been working to educate consumers around the benefits of creatine, and produce a high-quality creatine monohydrate with a smooth texture and neutral taste.
Cr.01 seeks to deliver high-purity creatine with tightly controlled manufacturing standards and independent batch verification, and is manufactured to comply with major international quality and safety standards, including FDA (USP) and EFSA requirements.
“Creatine has been the most under-positioned ingredient in human nutrition for three decades,” said Steve Jennings, who pioneered the introduction of creatine monohydrate supplementation to Olympic-level athletes in 1992. “The research is extraordinary—energy, cognition, healthy aging, neuroprotection—and almost none of it has reached the people it could help most.
“Jenerise Cr.01 is the ingredient that makes it possible for brands to finally tell that bigger story.”
France bans CBD edibles, European agency agrees on ‘reproductive toxicant’ classification
France has banned CBD edibles and convinced the European Chemicals Agency (ECHA) that CBD should be treated as a reproductive toxicant, adding pressure on an “already fragile and highly uncertain” market.
Effective May 15, the French General Directorate for Food (DGAL) prohibited the sale of CBD gummies, tinctures and supplements under EU Novel Food regulation without prior consultation with industry representatives.
Outlining the impact for the local hemp industry, the Union of Industries for the Valorization of Hemp Extracts (UIVEC), said this will affect nearly 2,000 hemp producers, 20,000 pharmacies, 1,500 CBD shops and several major retailers and independent stores, representing an estimated turnover of around €100 million for CBD-based food supplements alone.
“France, the historical European leader in hemp cultivation area, risks destroying its own competitive advantage at a time when other countries are actively structuring their markets,” it stated when the proposed ban was first announced.
“This is a major development, which represents another significant negative signal for the CBD sector,” commented Jerome Le Bloch, head of scientific affairs at FoodChain ID. “The industry has already faced major challenges linked to novel food authorization requirements, EFSA’s inability so far to confirm CBD safety and uncertainty around toxicological data. Against this backdrop, the proposed classification of CBD as a reproductive toxicant would add further pressure on an already fragile and highly uncertain European CBD supplements market.”
Senate bill would let HSAs & FSAs cover dietary supplements
Senators Kevin Cramer (R-ND) and John Curtis (R-UT) have introduced the Dietary Supplements Access Act to amend the Internal Revenue Code to recognize dietary supplements as qualified medical expenses eligible for reimbursement through Health Savings Accounts (HSAs) and Flexible Spending Arrangements (FSAs).
The bill, which would extend coverage for dietary supplements starting in 2027, also applies to Health Reimbursement Arrangements (HRAs) and Archer Medical Savings Accounts (MSAs), subject to annual limits.
“Nutritional supplements are a crucial form of preventative care, keeping people healthier in the long run and, ultimately, driving down healthcare costs,” said Sen. Cramer. “But right now, the rules don’t fully reflect this reality. By modernizing how health savings accounts and flexible spending accounts can be used, this bill gives families more freedom, more choice, and more ability to invest in their own wellbeing.”
Allowing consumers to use their HSAs, FSAs and HRAs to purchase dietary supplements has long been a key objective for the dietary supplement trade associations, with the National Products Association (NPA) and the Council for Responsible Nutrition (CRN) carrying that message to lawmakers during visits to lawmakers on Capitol Hill in recent years.
The new bill is supported by dietary supplement trade associations, including NPA, CRN and the Consumer Health Products Association (CHPA).
